Drew Ranieri

Stock Analyst at Morgan Stanley

(1.32)
# 1815
Out of 5,340 analysts
175
Total ratings
39.77%
Success rate
11.10%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Equal-Weight
4 6
3.1 93.55% 4 Mar 5, 2025
GMED Globus Medical
Upgrades: Overweight
83 100
61.29 63.16% 12 Dec 2, 2024
SYK Stryker
Upgrades: Overweight
370 445
394.22 12.88% 9 Dec 2, 2024
SIBN SI-BONE
Maintains: Overweight
21 19
19.75 -3.8% 15 Aug 6, 2024
IART Integra Lifesciences
Maintains: Underweight
24 27
13.57 98.97% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 8
6.72 19.05% 12 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 22
23.97 -8.22% 16 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
17.53 -54.36% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
19 16
12.95 23.55% 8 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 83
19.44 324.38% 10 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
10 8
n/a n/a 11 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 38
18.25 108.22% 9 Nov 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
88 96
70.4 36.36% 10 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
28 26
13.11 98.32% 8 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 295
175.4 68.19% 2 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
236 280
129.16 116.79% 5 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 5
6.78 -26.25% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
72 70
31.68 120.96% 4 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 54
n/a n/a 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
325 300
563.89 -46.8% 6 Apr 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
130 148
n/a n/a 1 Aug 2, 2021